We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Collaboration Expands Point-of-Care Testing Across UK Community Pharmacies

By LabMedica International staff writers
Posted on 25 Aug 2026

HealthTab, a wholly owned subsidiary of Avricore Health, has entered a formal collaboration agreement with Abbott to supply and distribute Abbott’s point-of-care testing products in the UK through the HealthTab platform. More...

Under the agreement, HealthTab will distribute the Abbott Afinion 2 Analyzer to National Health Service (NHS)-linked pharmacies for hemoglobin A1c (HbA1c) and lipid profile testing. The collaboration also establishes a framework for expanding point-of-care testing services across community pharmacy networks.

HealthTab provides a turnkey solution for pharmacy-based testing programs that includes instruments, consumables, onboarding, training, and ongoing support. At the center of the offering is a secure cloud platform that connects point-of-care analyzers with patient results, quality control data, and pharmacist workflows, creating a unified digital infrastructure across participating locations. The platform is designed to support quality-assured testing, standardized data capture, and real-time analytics for public health reporting and performance monitoring, while reducing implementation complexity for pharmacy partners.

To support analytical performance and reliability, HealthTab partners with CEQAL Inc., a reference method laboratory and member of the U.S. Centers for Disease Control and Prevention (CDC) Cholesterol Reference Method Laboratory Network. The quality program mirrors accredited clinical laboratories through centralized lot monitoring of reagents, mandated internal quality control, and regular external quality‑assessment events. These measures help ensure results generated across participating pharmacies are accurate, traceable, and consistent with internationally recognized reference standards.

“This agreement represents our most significant milestone to date,” said Rodger Seccombe, CEO of Avricore Health. “We’ve spent fifteen years building and proving the model for pharmacy-based point-of-care testing, and we’ve learned that solving this problem takes more than great technology — it takes an industry-leading partner willing to invest the people, expertise, and resources needed to make it successful. We couldn’t have asked for a better team to be working with, and together we’re going to make a real impact on patient care.” 

Related Links
Avricore Health
Abbott


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical Abstract (Ziegler, AG., Rewers, M.J., Achenbach, P. et al. Diabetologia (2026). https://doi.org/10.1007/s00125-026-06841-z)

International Consensus Guidance Outlines General Population Screening for Early-Stage Type 1 Diabetes

Type 1 diabetes (T1D) is an autoimmune disease that can develop in childhood or adulthood and affects an estimated 9.5 million people worldwide. Its complications range from acute diabetic ketoacidosis... Read more

Microbiology

view channel
Image: The current BDBV outbreak in the DRC underscores response challenges for rare, severe infections (Image Credit: 123RF)

Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics

Bundibugyo virus (BDBV), a species of ebolavirus, causes severe hemorrhagic disease and can be difficult to diagnose rapidly during outbreaks. Recent regulatory changes have further complicated swift deployment... Read more

Technology

view channel
Image: The 5811 R retains the performance and versatility of its predecessor while adding a new design, a refreshed user interface, and updated sustainable cooling technology. (Photo courtesy of Eppendorf)

New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling

Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.